Letter to the World Health Organization (WHO)
Letter to the World Health Organization (WHO) and delegates of the Ninth Conference of Parties (COP9) regarding the Framework Convention…
US Food & Drug Administration, Modified Risk Tobacco Product Applications Draft Guidance
- In 2019, the US Food and Drug Administration (FDA) granted its first-ever risk modified order to a range of nicotine products.
- To qualify, the products had to demonstrate that they:
- “Significantly reduce harm and the risk of tobacco-related disease to individual tobacco users.”
- “Benefit the health of the population as a whole taking into account both users of tobacco products and persons who do not currently use tobacco products.”
- Since 2019, it has granted modified risk status to a range of nicotine pouches and electronic devices.
- These products can be advertised and labelled as being less harmful than cigarettes.
Related Posts
Public Health implications of vaping in Germany
Public Health implications of vaping in Germany
Prof Levy’s SAVM model predicts 4.7 million life-years saved, and 300,000 deaths avoided by 2060 In Germany’s population of 84…
Public Health implications of vaping in the United States of America
Public Health implications of vaping in the United States of America
Public health implications of vaping in USA: Prof Levy’s SAVM model predicts 38.9 million life-years saved, and 1.8 million deaths…
